H. Verhaegen

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

A. Van de Water, Wim Janssens, J. Van Neuten et al. · Journal of Cardiovascular Pharmacology · 1988 · 199 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +21

Renal involvement in sarcoidosis

E Lebacq, H. Verhaegen, V. Desmet · Postgraduate Medical Journal · 1970 · 96 citations · Full text

Glomerular Disease, Sarcoidosis Patients, Renal Pathology +18

Determining the cause of death in randomized screening trial(s) for prostate cancer

Harry J. de Koning, J. Blom, J.W. Merkelbach et al. · British Journal of Urology · 2003 · 89 citations

Urology, Cancer Detection, Cancer Screening +7

Unchanged levels of interleukins, neopterin, interferon-γ and tumor necrosis factor-α in cerebrospinal fluid of patients with dementia of the Alzheimer type

S. Engelborghs, M. De Brabander, J. De Crée et al. · Neurochemistry International · 1999 · 70 citations

Neurodegenerative Diseases, Alzheimer Type, Alzheimer's Disease +14

Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta‐1‐adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol

J. De Crée, H. Geukens, J. Leempoels et al. · Drug Development Research · 1986 · 68 citations

Hypertension, R 67555, Cardiometabolic Risk +27